{"id":57485,"date":"2016-03-28T13:18:03","date_gmt":"2016-03-28T13:18:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=57485"},"modified":"2016-03-28T13:18:03","modified_gmt":"2016-03-28T13:18:03","slug":"us-generic-drugs-market-market-trends-generic-drug-manufacturers-opportunities-and-market-outlook","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/us-generic-drugs-market-market-trends-generic-drug-manufacturers-opportunities-and-market-outlook_57485.html","title":{"rendered":"US Generic Drugs Market: Market Trends, Generic Drug Manufacturers, Opportunities and Market Outlook"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.getnews.info\/wp-content\/uploads\/2016\/03\/a1459165377.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.getnews.info\/wp-content\/uploads\/2016\/03\/a1459165377.jpeg\" alt=\"\" width=\"225\" height=\"287\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The market for generic drugs in the United States is currently being catalyzed by a number of factors. This includes the lower cost of generics, patent expiries of blockbuster branded drugs, savings for the government and insurance providers, increasing ageing population and a rising prevalence of chronic diseases.<\/div>\n<p style=\"text-align: justify;\">The report entitled <strong>&ldquo;US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook&rdquo;<\/strong> represents an in-depth analysis on the historical, current and future trends in the <a rel=\"nofollow\" title=\"US generics market\" href=\"http:\/\/www.imarcgroup.com\/us-generics-market\" target=\"_blank\">US generics market<\/a>. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the US generics market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the US generics market in any form.<\/p>\n<p style=\"text-align: justify;\"><strong>Key Questions Answered in This Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>What are generic drugs and how are they different from branded drugs?<\/li>\n<li>How have the US generics market performed in recent years?<\/li>\n<li>How have generics performed compared to branded drugs?<\/li>\n<li>What were the total sales and prescriptions for generics in the US?<\/li>\n<li>Who are the key players in the US generics market and how have they performed?<\/li>\n<li>&nbsp;What is the structure of the US generics market?<\/li>\n<li>Which are the most prescribed generics in the US?<\/li>\n<li>What is the pricing mechanism of generics in the US?<\/li>\n<li>What is the value chain of generics in the US?<\/li>\n<li>What are the regulations for generics in the US?<\/li>\n<li>How are generics distributed in the US?<\/li>\n<li>How are generics manufactured?<\/li>\n<li>What are the raw material and machinery requirements to manufacture generics?<\/li>\n<li>What are the drivers and challenges in the US generics market?<strong><br \/><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><br \/>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>1 Research Methodology and Market Definitions<\/strong><br \/> <strong>2 Report Summary<\/strong><br \/> <strong>3 US Generics Market &ndash; Introduction<\/strong><br \/> 3.1 What are Generics?<br \/> 3.2 Unbranded and Branded Generics<br \/> 3.3 Authorized Generics<br \/> 3.4 Commoditised and Specialty Generics<br \/> <strong>4 Why is the US Generics Market so Lucrative<\/strong><br \/> 4.1 Patent Expiry of Blockbuster Drugs<br \/> 4.2 Significant Price Differential Between Generics and Innovator Drugs<br \/> 4.3 Savings for the Government and Third Party Payers<br \/> 4.4 Incentives for Dispensing and Prescribing Generics<br \/> 4.5 Reimbursement and Lower Copayments<br \/> 4.6 Biosimilars<br \/> <strong>5 Global Generics Market<\/strong><br \/> 5.1 Current and Historical Market Trends<br \/> 5.2 Market Breakup by Country: The United States Represents the World&rsquo;s Biggest Market<br \/> 5.3 Market Forecast<br \/> <strong>6 US Generics Market<\/strong><br \/> 6.1 US Pharmaceutical Market &ndash; Current and Historical Market Trends<br \/> 6.2 US Pharmaceutical Market &ndash; Share of Branded and Generic Drugs<br \/> 6.3 US Generics Market &ndash; Current and Historical Sales Trends<br \/> 6.4 US Generics Market &ndash; Current and Historical Volume Trends<br \/> 6.5 US Generics Market &ndash; Market Breakup By Segment<br \/> <strong>7 US Generics Market- Competitive Landscape<\/strong><br \/> 7.1 US Generics Market &ndash; Competitive Structure<br \/> 7.2 US Generics Market &ndash; Sales Breakup of Key Players<br \/> 7.3 US Generics Market &ndash; Volume Breakup of Key Players<br \/> 7.4 US Generics Market &ndash; Most Prescribed Generic Drugs<br \/> 7.5 US Generics Market &ndash; Market Breakup By Distribution<br \/> 7.6 US Generics Market &ndash; Pricing Dynamics<br \/> <strong>8 US Generics Market &ndash; Value Chain Analysis<\/strong><br \/> 8.1 Research and Development<br \/> 8.2 Manufacturing<br \/> 8.3 Marketing and Distribution<br \/> <strong>9 Regulations in the US Generics Industry<\/strong><br \/> 9.1 Overview of Pharmaceutical Regulations<br \/> 9.2 Drug Applications<br \/> 9.3 Patents and Market Exclusivity<br \/> 9.4 Regulatory Requirement For Generics<br \/> 9.5 The Hatch-Waxman Act<br \/> 9.6 Possible Certifications<br \/> 9.7 Other Important Considerations<br \/> <strong>10 US Generics Market: Key Success Factors<\/strong><br \/> <strong>11 US Generics Market: Road Blocks<\/strong><br \/> <strong>12 Requirements for Setting Up a Generic Drug Manufacturing Plant<\/strong><br \/> 12.1 Manufacturing Process<br \/> 12.2 Raw Material Requirements<br \/> 12.3 Machinery and Infrastructure Requirements<br \/> <strong>13 US Generic Market &ndash; Key Company Profiles<\/strong><br \/> 13.1 Teva<br \/> 13.2 Mylan<br \/> 13.3 Actavis<br \/> 13.4 Sandoz<br \/> 13.5 Sun Pharma<br \/> 13.6 Par Pharmaceuticals<br \/> 13.7 Endo Pharmaceuticals<br \/> 13.8 Lupin Pharmaceuticals<br \/> 13.9 Dr Reddy&rsquo;s<br \/> 13.10 Hospira<\/p>\n<p style=\"text-align: justify;\"><strong>List of Figures<\/strong><\/p>\n<p style=\"text-align: justify;\">Figure 3 1: Structure of the Pharmaceutical Industry<br \/> Figure 3 2: Classification of Generics<br \/> Figure 4 1: United States: Patent Expiry Exposure (in Billion US$)<br \/> Figure 4 2: United States: Savings From Generic Drugs (in Billion US$), 2005-2015<br \/> Figure 5 1: Global: Generics Market: Sales Value (in Billion US$), 2011-2015<br \/> Figure 5 2: Global: Generics Market: Sales Volume (in Billion SU), 2011-2015<br \/> Figure 5 3: Global: Generics Market: Sales Value Breakup By Country (in %), 2015<br \/> Figure 5 4: Global: Generics Market: Sales Volume Breakup by Country (in %), 2015<br \/> Figure 5 5: Global: Generics Market Forecast: Sales Value (in Billion US$), 2016-2021<br \/> Figure 5 6: Global: Generics Market: Sales Volume (in Billion SU), 2016-2021<br \/> Figure 6 1: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2011-2015<br \/> Figure 6 2: US: Pharmaceutical Market: Sales Value (in US$ Billion), 2011-2015<br \/> Figure 6 3: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2011 &amp; 2015<br \/> Figure 6 4: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2011 &amp; 2015<br \/> Figure 6 5: US: Generics Market: Sales Value (in Billion US$), 2011-2015<br \/> Figure 6 6: US: Generics Market Forecast: Sales Value (in US$ Billion), 2016-2021<br \/> Figure 6 7: US: Generics Market: Sales Volume (in Million Prescriptions), 2011-2015<br \/> Figure 6 8: US: Generics Market Forecast: Sales Volume (in Million Prescriptions), 2016-2021<br \/> Figure 6 9: US: Generics Market: Market Breakup by Segment (in %), 2011-2015<br \/> Figure 7 1: United States: Generics Market: Sales Share of Top Players (in %), 2015<br \/> Figure 7 2: United States: Generics Market: Volume Share of Top Players (in %), 2015<br \/> Figure 7 3: United States: Generics Market: Volume Share by Distribution (in %), 2015<br \/> Figure 7 4: United States: Generic Drug Prices as a Percentage of Branded Drug Prices &ndash; Based on Number of Competitors (in Billion US$)<br \/> Figure 8 1: United States &ndash; Generics Market &ndash; Value Chain Analysis<\/p>\n<p style=\"text-align: justify;\"><strong>List of Tables<\/strong><\/p>\n<p style=\"text-align: justify;\">Table 4 1: United States: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)<br \/> Table 5 1: Global &ndash; Generics Market: Sales, Volume and Growth of Major Markets, 2015<br \/> Table 7 1: United States: Generics Market: Sales Performance of Top Players (in US$ Million), 2015<br \/> Table 7 2: United States: Generics Market: Volume Performance of Top Players (in Million Prescriptions), 2015<br \/> Table 7 3: United States: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2015<br \/> Table 9 1: United States: Overview of Pharmaceutical Regulations<\/p>\n<p style=\"text-align: justify;\"><strong><br \/>To buy the complete report or to get a&nbsp;free sample, please contact:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>IMARC Group Asia: <\/strong><br \/> Email:&nbsp;apac@imarcgroup.com<br \/> Phone: +91-120-415-5099&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>IMARC Group North America:<\/strong><br \/> Email: america@imarcgroup.com<br \/> Phone: +1-631-791-1145<\/p>\n<p style=\"text-align: justify;\"><strong>IMARC Group Europe, Middle East &amp; Africa:<\/strong><br \/> Email: ema@imarcgroup.com<br \/> Phone: +44-702-409-7331&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To know more please visit: <\/strong><a rel=\"nofollow\" href=\"http:\/\/www.imarcgroup.com\/us-generics-market\">http:\/\/www.imarcgroup.com\/us-generics-market<\/a><\/p>\n<p style=\"text-align: justify;\"><strong><br \/>About IMARC Group<\/strong><\/p>\n<p style=\"text-align: justify;\">The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.<\/p>\n<p style=\"text-align: justify;\">IMARC&rsquo;s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company&rsquo;s expertise.<\/p>\n<p style=\"text-align: justify;\"><strong>To know more about our company, please visit:<\/strong>&nbsp;<a rel=\"nofollow\" title=\"IMARC Group\" href=\"http:\/\/www.imarcgroup.com\/\" target=\"_blank\">http:\/\/www.imarcgroup.com\/<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> IMARC Group<br \/><strong>Contact Person:<\/strong> Krishna Sharma<br \/><strong>Email:<\/strong> sales@imarcgroup.com<br \/><strong>Phone:<\/strong> +91-120-415-5099<br \/><strong>Address:<\/strong>G B Nagar Noida Complex  <br \/><strong>City:<\/strong> Noida<br \/><strong>State:<\/strong> Uttar Pradesh<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.imarcgroup.com\/\" target=\"_blank\" rel=\"nofollow\">http:\/\/www.imarcgroup.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.imarcgroup.com\/\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=us-generic-drugs-market-market-trends-generic-drug-manufacturers-opportunities-and-market-outlook\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook&#8221; The market for generic drugs in the United States is currently being catalyzed by a number of factors. This includes the lower cost of generics, patent expiries of blockbuster branded &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/us-generic-drugs-market-market-trends-generic-drug-manufacturers-opportunities-and-market-outlook_57485.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-57485","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/57485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=57485"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/57485\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=57485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=57485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=57485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}